The Official Journal of EuroPCR and the European Association of Percutaneous Cardiovascular Interventions (EAPCI)
This expert consensus provides guidance on using renal denervation for resistant hypertension based on recent randomized controlled trial results.
First-in-human experience with a new coronary sinus reducer device for the treatment of refractory angina.
The Official Journal of EuroPCR and the European Association of Percutaneous Cardiovascular Interventions (EAPCI)
Study on adverse events after PFO closure in older patients with cryptogenic thromboembolic events.
Comparison of simplified versus conventional antithrombotic treatment after left atrial appendage occlusion in very high bleeding risk patients.
Review of device-related thrombotic risk and antithrombotic management for transcatheter structural heart interventions.
Retrospective study comparing clinical features and outcomes of acute limb ischemia caused by femoropopliteal stent thrombosis versus other etiologies.
Find out more about this article on Is it time for a myocardial infarction approach to high- and intermediate-high-risk pulmonary embolism?
The Official Journal of EuroPCR and the European Association of Percutaneous Cardiovascular Interventions (EAPCI)
The Official Journal of EuroPCR and the European Association of Percutaneous Cardiovascular Interventions (EAPCI)
